BRAIN BEHAVIOR AND IMMUNITY is a premier academic journal published by ACADEMIC PRESS INC ELSEVIER SCIENCE, focusing on the intricate relationships between the nervous and immune systems. With an impressive impact factor and consistent ranking in the top quartile (Q1) across several categories such as Behavioral Neuroscience, Endocrine and Autonomic Systems, and Immunology, this journal stands out as a critical resource for researchers and professionals in these rapidly evolving fields. Since its inception in 1987, the journal has committed to publishing high-quality, peer-reviewed research that advances our understanding of immunological processes as they relate to behavior and mental health. Though it does not currently offer Open Access, it is widely accessible to institutional libraries and professionals, ensuring that groundbreaking research reaches a broad audience. As the field continues to expand, BRAIN BEHAVIOR AND IMMUNITY remains a vital platform for innovative studies and reviews that bridge the gap between neuroscience and immunology, making it an essential read for academics, clinicians, and students dedicated to furthering research in this interdisciplinary domain.

Current Opinion in Behavioral Sciences, published by ELSEVIER, is a premier academic journal that provides insightful and comprehensive reviews of contemporary research in the fields of behavioral neuroscience, cognitive neuroscience, and psychiatry and mental health. With an impressive Q1 ranking in multiple categories and Scopus rankings that highlight its influence—4th in Behavioral Neuroscience and 8th in Cognitive Neuroscience—this journal has positioned itself as a leading platform for disseminating high-quality scholarly work. Accessible to readers in the United Kingdom and beyond, it plays a vital role in advancing knowledge and understanding of behavioral science and its applications. Its impact is further underscored by its percentile rankings in key fields, making it an essential resource for researchers, professionals, and students seeking to stay abreast of the latest developments and trends from 2015 to 2024. This journal aims to bridge the gap between cutting-edge research and practical application, fostering a collaborative and interdisciplinary approach to pressing issues in behavioral sciences.

Developmental Neurobiology, published by WILEY, is a premier peer-reviewed journal dedicated to advancing our understanding of the neurobiological processes that underpin development throughout the lifespan. With its ISSN 1932-8451 and E-ISSN 1932-846X, this journal targets a sophisticated audience of researchers and professionals in the fields of developmental and cellular neuroscience. The journal not only boasts an impressive impact factor but also maintains a highly regarded reputation, reflected in its 2023 rankings where it sits in the Q1 category for Developmental Neuroscience and Q2 for Cellular and Molecular Neuroscience. Positioned in the United States and active from 2007 to 2024, Developmental Neurobiology serves as a critical platform for disseminating groundbreaking research and innovative findings, ensuring accessible knowledge through its Open Access options. By bridging molecular mechanisms with developmental processes, the journal plays a vital role in paving the way for future discoveries in neurobiology, making it an essential resource for academics, students, and practitioners dedicated to understanding the complexities of the nervous system.

CELL STRESS & CHAPERONES is a renowned journal that has been at the forefront of advancing our understanding of protein folding, cellular stress responses, and the role of chaperone proteins since its inception in 1996. Published by SPRINGER, this esteemed journal operates out of the Netherlands and serves as a critical platform for researchers in the fields of Biochemistry and Cell Biology. With an impressive impact factor reflecting its credibility—ranked Q2 in Biochemistry and Q3 in Cell Biology for 2023—it showcases rigorous, peer-reviewed research that contributes significantly to the understanding of cellular mechanisms and their implications in health and disease. The journal's commitment to disseminating high-quality research is evident through its indexed status ranking in the Scopus database, identifying it among the top quartile of publications in its respective categories. For scholars and practitioners dedicated to exploring the intricate relationship between cellular stress and physiological responses, CELL STRESS & CHAPERONES provides a vital resource, fostering an interdisciplinary dialogue that enhances the scientific community's collective knowledge.

FRONTIERS IN NEUROENDOCRINOLOGY, published by Academic Press Inc, Elsevier Science, is a leading peer-reviewed journal dedicated to advancing the understanding of neuroendocrinology, focusing on the intricate interactions between the nervous system and endocrine functions. Established in 1973, this esteemed publication has consistently demonstrated its significance in the field, achieving a category quartile ranking of Q1 in Endocrine and Autonomic Systems for 2023, and securing a remarkable 93rd percentile in the Scopus Rankings. Though the journal is not open-access, it is widely recognized for its high-quality research articles that provide crucial insights into the neuroendocrine mechanisms underlying various physiological processes and disorders. As it continues to bridge gaps in knowledge from 1990 through to 2024, FRONTIERS IN NEUROENDOCRINOLOGY is essential for researchers, professionals, and students alike, aiming to foster collaboration and innovation within the dynamic landscape of neuroendocrine science.

NEUROCHEMISTRY INTERNATIONAL, published by Pergamon-Elsevier Science Ltd, offers a premier platform for researchers and professionals in the realms of cell biology and cellular and molecular neuroscience. Established in 1980 and continuing its passion for advancing the field, this esteemed journal enhances scientific collaboration with a notable 2023 Q2 ranking in both relevant categories, placing it among the top-tier publications in its discipline with a Scopus rank of 23/97 for Cellular and Molecular Neuroscience. With its focus on groundbreaking research, the journal provides a wealth of vital data and insights that drive forward our understanding of neurochemistry and its implications in health and disease. While not an Open Access journal, NEUROCHEMISTRY INTERNATIONAL is integral for professionals, academics, and students aiming to stay at the forefront of neurobiological research innovations, making significant contributions to both academia and clinical applications.

STRESS AND HEALTH is a premier journal published by Wiley that serves as a vital platform for advancing knowledge in the intersection of psychology, medicine, and mental health. With its ISSN 1532-3005 and E-ISSN 1532-2998, the journal has established itself as a leading resource for researchers and practitioners focusing on the physiological and psychological impacts of stress and health outcomes. With a remarkable impact factor and classified in the prestigious Q1 quartile across categories such as Applied Psychology, Clinical Psychology, Medicine (miscellaneous), and Psychiatry and Mental Health, STRESS AND HEALTH publishes high-quality, peer-reviewed research that aims to explore innovative methodologies and evidence-based interventions. Offering both subscription and open access options, the journal is dedicated to disseminating critical insights and enhancing the understanding of stress and health dynamics. For over two decades, from 2001 to 2024, it has contributed significantly to the global discourse on health challenges, making it an essential reference for academics, clinicians, and students alike.

Cell Death Discovery, published by Springer Nature, is a distinguished open-access journal dedicated to advancing the field of cell death research. Since its inception in 2015, the journal has rapidly established itself as a premier platform for high-quality research, currently holding a remarkable position in the Q1 quartiles across multiple categories, including Cancer Research, Cell Biology, Cellular and Molecular Neuroscience, and Immunology. With an impact factor reflecting its significant contribution to the scientific community, Cell Death Discovery invites submissions that explore the molecular mechanisms of cell death and its implications across various biomedical fields. The journal's open-access model ensures that groundbreaking research is accessible to a global audience, facilitating collaboration and dissemination among researchers, professionals, and students alike. Located in the UK, at CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND, the journal continues to support innovative scholarship and foster a deeper understanding of the processes behind cell viability, development, and disease.

NATURE NEUROSCIENCE is a premier journal published by NATURE PORTFOLIO, focusing on cutting-edge research in the field of neuroscience. With an esteemed impact factor that reflects its significance in the academic community, this journal occupies an exceptional place in the 2023 Q1 category for neuroscience (miscellaneous) and boasts a leading Scopus rank of #1 out of 113 in general neuroscience, placing it within the top 1st percentile. Since its inception in 1998, NATURE NEUROSCIENCE has consistently delivered high-quality, peer-reviewed articles that contribute to our understanding of the nervous system, driving innovation and scholarship across disciplines. Although it does not offer open access, the journal remains a vital resource for researchers, professionals, and students seeking to stay at the forefront of neuroscientific discovery and discussion. Its editorial commitment to excellence ensures that it continually shapes the trajectory of neuroscience research well into 2024 and beyond, making it an indispensable asset for anyone passionate about the brain and its complexities.

METABOLIC BRAIN DISEASE, published by SPRINGER/PLENUM PUBLISHERS, is a leading journal dedicated to advancing our understanding of the metabolic processes impacting brain health and disease. Established in 1986 and set to continue until 2024, this journal encompasses a wide range of interdisciplinary research that intersects the fields of Biochemistry, Cellular and Molecular Neuroscience, and Neurology, as evidenced by its notable quartile placements in Q2 and Q3 for 2023. With an ISSN of 0885-7490 and an E-ISSN of 1573-7365, it serves as a vital resource for researchers and practitioners aiming to deepen their insights into cerebral metabolic disorders and their implications. Although currently not an Open Access option, its rigorous peer-review process ensures that high-quality, impactful research reaches its audience. Showcasing a significant rank within the top percentile of its categories, METABOLIC BRAIN DISEASE is instrumental in shaping the future of neurological research and clinical applications.